Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $694,275 - $805,275
7,500 New
7,500 $798,000
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $7.56 Million - $8.57 Million
81,700 New
81,700 $8.24 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $1.59 Million - $1.94 Million
21,000 New
21,000 $1.91 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $7.61 Million - $8.61 Million
-95,000 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $4.22 Million - $4.67 Million
53,003 Added 126.21%
95,000 $8.31 Million
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $1.8 Million - $2.09 Million
21,997 Added 109.99%
41,997 $3.44 Million
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $1.67 Million - $1.97 Million
20,000 New
20,000 $1.71 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $404,650 - $455,500
-5,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $353,350 - $495,050
5,000 New
5,000 $412,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.